Significant Advances in the Treatment of Corona Virus

Significant advances in the treatment of corona virus

 

Cholesterol-lowering drugs Statins can help reduce the rate of 

mortality and medical ventilation by helping treat novice coronavirus. 

This was revealed in a new medical study.

The drug is commonly used to lower cholesterol levels while 

preventing lung cancer from progressing in animals, improving the 

immune response and reducing inflammation, all three of which are 

common in patients with COVID-19.

 

The study, published in the medical journal Cell Metabolism by 

Chinese experts, examined the use of statins in about 14,000 patients.

 

The researchers found that people who used the drug had a 45% 

reduction in mortality.

 

Researchers also found that using statins with blood pressure-lowering

drugs did not increase the risk of death.

 

Experts involved in the Wuhan University study said the results 

showed that the drug was safe and beneficial for patients undergoing 

treatment at a hospital in COVID-19.

Although research has not shown a definitive reduction in mortality, 

it does provide an anticipation of a possible cure.

 

The researchers said that although the data showed evidence that the 

drug was safe, its effectiveness should be tested in more trials with 

reference to COVID-19.

There is no vaccine or treatment for coronavirus yet, but trials of 

statins and remedies have so far been positive.

Earlier this week, a study in the United States found that glucosamine 

or metformin, a drug available to diabetics, also helped prevent the 

worst effects of the corona virus.

A pre-printed study from the University of Minnesota (a study not 

published in a medical journal) found that the drug, which is readily 

available everywhere, could help prevent the effects of the corona 

virus.

This is one of the few major observational studies on the risk factors 

for corona virus, which found that obesity and diabetes are the two 

leading causes of death from COVID-19.

But at the same time, it was discovered that the risk of dying from 

corona virus with glucofage can be reduced by 21 to 24% in patients 

who are already using the drug to control their diabetes and blood 

sugar levels.

The researchers said that people should not consider this drug as a 

cure for the virus, but the results could open new avenues for 

controlling infectious diseases such as COVID-19.

He said the drug could potentially be helpful for patients with 

COVID-19 because it reduces the body's immune response while 

reducing inflammation.

In some cases of the coronavirus, a highly active immune system can 

cause death.

The new study looked at more than 6,000 people who had diabetes or 

obesity and were hospitalized as a result of COVID-19.

The researchers found that the number of deaths from the epidemic 

was reduced in women who were prescribed diabetes medication.

Taking into account other risk factors, it has been estimated that the 

use of this drug can reduce the risk of death from COVID-19 by 21 to 

24 percent, but this relationship has not been observed in men.

"We already know that this drug affects men and women in different 

ways. In a study to prevent diabetes, we discovered that it can cause 

CRP (inflammation) The level of a protein is twice as low in women 

as in men.

The drug also lowers the level of the TNF alpha, a protein that causes 

inflammation in patients with COVID-19, which makes the condition 

worse, especially in women who have lower levels than men.